Skip to main content
45°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nuvation Bio Inc
(NY:
NUVB
)
2.700
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nuvation Bio Inc
< Previous
1
2
3
4
Next >
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 26, 2024
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 26, 2024
Via
Benzinga
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
March 26, 2024
U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Expectations for Nuvation Bio's Future
March 24, 2023
Via
Benzinga
Where Nuvation Bio Stands With Analysts
March 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 25, 2024
Via
Benzinga
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
March 25, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
March 25, 2024
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors
March 14, 2024
From
Nuvation Bio Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 14, 2024
Via
Benzinga
Biotech’s Role in Addressing the Pancreatic Cancer Emergency
March 14, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END
Via
FinancialNewsMedia
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 29, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors
January 08, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors
January 08, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Announces Departure of Chief Financial Officer
November 13, 2023
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
November 02, 2023
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio And 3 Other Stocks Under $4 Insiders Are Buying
September 22, 2023
The Dow Jones closed lower by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
August 03, 2023
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board
June 01, 2023
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update
May 04, 2023
From
Nuvation Bio Inc.
Via
Business Wire
The 7 Worst Stocks to Buy Now
March 18, 2023
With the market reeling from the banking crisis, even hardened gamblers should avoid these worst stocks to buy now.
Via
InvestorPlace
Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 15, 2023
From
Nuvation Bio Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
Via
Benzinga
Nuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868
December 19, 2022
From
Nuvation Bio Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
November 18, 2022
On Friday, 64 companies achieved new lows for the year.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
On Wednesday, 70 companies set new 52-week lows.
Via
Benzinga
Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
November 03, 2022
From
Nuvation Bio Inc.
Via
Business Wire
Netflix Price Target Cut By This Analyst, Plus Morgan Stanley Predicts $403 For McKesson
August 22, 2022
UBS cut the price target for Coupa Software Incorporated (NASDAQ: COUP) from $84 to $76. Coupa Software shares fell 4.9% to $64.44 in pre-market trading.
Via
Benzinga
Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update
August 04, 2022
From
Nuvation Bio Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
August 03, 2022
Wednesday's session saw 51 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.